Breeders Group CIOPORA Calls For New Plant Varieties To Be Patentable 23/11/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment A new “position paper” by a plant breeders industry group revives the argument that plant-related inventions should be patentable. New plant breeding techniques modifying the plant genome are not essentially biological processes, thus should be patentable, the paper says. The group also calls for a worldwide harmonised research exemption on plant variety rights and patents for the purpose of improving the invention.
Brexit Drives European Medicines Agency To The Netherlands, Move By March 2019 21/11/2017 by Intellectual Property Watch Leave a Comment As a consequence of the decision of the United Kingdom to go its separate way, the remaining European Union member states decided yesterday that the European Medicines Agency should move to Amsterdam by the end of March 2019.
ITU Report Analyzes Revolution In Internet Of Things, Big Data, Cloud, AI 15/11/2017 by Intellectual Property Watch 1 Comment The UN International Telecommunication Union (ITU) today released its annual report on the global information society, this year providing detailed analysis of the transformational “revolution” underway involving the Internet of Things, big data, cloud computing and artificial intelligence. It also ranked countries by their level of ICT development. Hint: the Western Hemisphere did not fare so well.
Infojustice – US, Canadian & Mexican Law Professors, Academics And Policy Experts: NAFTA Must Include Fair Use, Safe Harbors 15/11/2017 by Intellectual Property Watch 1 Comment WASHINGTON – Today, over seventy international copyright law experts called for NAFTA and other trade negotiators to support a set of balanced copyright principles. The experts urge trade negotiators to support policies like fair use, safe harbor provisions, and other exceptions and limitations that permit and encourage access to knowledge, flourishing creativity, and innovation. Signatories include preeminent intellectual property professors and experts from law schools, think tanks, and public interest organizations in the U.S., Canada, and Mexico, as well as Argentina, Australia, China, Ireland, and Switzerland.
Special Report: A Look Behind Hepatitis C Patent Challenges Worldwide 15/11/2017 by Tatum Anderson for Intellectual Property Watch 2 Comments A case at the High Court in India set for 15 December could decide whether a patent on some of the most important drugs to fight hepatitis C should be removed. It is one of many attempts to challenge patents on hepatitis C drugs in various countries around the world and serves as an opportunity to learn more about the group leading the legal case.
US Congress Members Signal Move To Block Allergan Patent Deal With Tribe 14/11/2017 by William New, Intellectual Property Watch Leave a Comment Members of a US congressional subcommittee on intellectual property held a hearing last week that appeared aimed at finding ways to stop companies from “renting” the sovereignty of Native American tribes in order to avoid a process that can lead to the invalidation of patents. Elected officials called a deal between Allergan pharmaceutical company and a northeastern tribe a “sham” and a “mockery”, and signalled the start of the legislative procedure to prevent such deals.
WIPO Hosts Widely Represented Discussion On Vaccine Innovation And Access 09/11/2017 by Catherine Saez, Intellectual Property Watch 1 Comment A well-represented set of experts this week held discussions on the current situation of access to vaccines, the market, the role of pharmaceutical companies, and partnerships. Vaccines were not a field much affected by patents in the past, but the situation has changed and new vaccines are now covered by intellectual property, which might constitute a barrier to access, according to speakers.
South Centre: Clear Rules Needed On Biosimilars Equivalence To Help Market Entry, Lower Prices 09/11/2017 by Intellectual Property Watch Leave a Comment As soon as 2022, biological drugs made from active protein substances are expected to make up 50 percent of the pharmaceutical market, as they are increasingly used to treat a number of illnesses such as diabetes, cancer and hepatitis. But with the high price of therapeutics and difficulty in producing biologically similar products, and with the originator products now coming off patent, regulation is of high importance, says a new report from the intergovernmental South Centre.
Geneva Buzzing With Ideas And Events For International Entrepreneurship Week 09/11/2017 by Intellectual Property Watch Leave a Comment A weeklong event next week has been co-organised and sponsored by a number of Geneva actors, such as the World Intellectual Property Organization, the European Organization for Nuclear Research (CERN), and the University of Geneva, as well as lesser known groups and projects, to celebrate the international week of entrepreneurship.
How Solid IP Security Policy Could Have Prevented The Waymo vs. Uber Legal Debacle 08/11/2017 by Bruce Gain for Intellectual Property Watch Leave a Comment Waymo likely could have avoided a lawsuit against Uber over driverless car technology if it had an effective policy to prevent trade theft by its employees, legal and security experts say.